ID

22332

Beschrijving

A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD) Medicine: rosiglitazone, Condition: Alzheimer's Disease, Phase: 2, Clinical Study ID: 49653/461, Sponsor: GSK Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1

Link

https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1

Trefwoorden

Versies (1)
  1. 30-05-17 30-05-17 -
Geüploaded op

30 mei 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Pregnancy Information Study Conclusion Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

Engels

Pregnancy Information Study Conclusion Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

1 Formulieren  
Pregnancy Information
Beschrijving

Pregnancy Information

Alias
UMLS CUI-1
C0032961
UMLS CUI-2
C1533716
Did patient become pregnant during the study? (mark one box below) -> If "yes" record details on Pregnancy Notification Form
Beschrijving

Pregnancy

Datatype

integer

Alias
UMLS CUI [1]
C0032961
Did the female partner of a male patient become pregnant during the study? (mark one box below) --> if "yes" record details on Pregnancy Notification Form.
Beschrijving

Female of childbearing potential

Datatype

integer

Alias
UMLS CUI [1]
C1960468
Study Conclusion
Beschrijving

Study Conclusion

Alias
UMLS CUI-1
C1707478
UMLS CUI-2
C0008972
Did the patient complete the study as planned?
Beschrijving

Study completion

Datatype

boolean

Alias
UMLS CUI [1]
C2826674
If "no", mark the one most appropriate category
Beschrijving

Specification

Datatype

integer

Alias
UMLS CUI [1]
C2348235
Please specify "Other"
Beschrijving

Other diseases

Datatype

text

Alias
UMLS CUI [1]
C2359476
Comments on reason for withdrawal:
Beschrijving

Withdrawal

Datatype

text

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0392360
Date of Withdrawal
Beschrijving

Date of Withdrawal

Datatype

date

Maateenheden
  • dd/mm/yyyy
Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0011008
dd/mm/yyyy
Time of Withdrawal
Beschrijving

Time of Withdrawal

Datatype

time

Maateenheden
  • hr:min
Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0040223
hr:min
Date of Final Dose:
Beschrijving

therapy end date

Datatype

date

Maateenheden
  • dd/mm/yyyy
Alias
UMLS CUI [1]
C1531784
dd/mm/yyyy
Time of Final Dose
Beschrijving

Pharmaceutical Preparations

Datatype

time

Maateenheden
  • hr:min
Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C1522314
hr:min
Terug naar het begin van de pagina

Similar models

Pregnancy Information Study Conclusion Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Pregnancy Information
C0032961 (UMLS CUI-1)
C1533716 (UMLS CUI-2)
Item
Did patient become pregnant during the study? (mark one box below) -> If "yes" record details on Pregnancy Notification Form
integer
C0032961 (UMLS CUI [1])
Pregnancy
Code List
Did patient become pregnant during the study? (mark one box below) -> If "yes" record details on Pregnancy Notification Form
CL Item
Not applicable (not of childbearing potential) (1)
CL Item
No (2)
CL Item
Yes (3)
Item
Did the female partner of a male patient become pregnant during the study? (mark one box below) --> if "yes" record details on Pregnancy Notification Form.
integer
C1960468 (UMLS CUI [1])
Female of childbearing potential
Code List
Did the female partner of a male patient become pregnant during the study? (mark one box below) --> if "yes" record details on Pregnancy Notification Form.
CL Item
Not applicable (subject is female, female partner not of childbearing potential or female partner) (1)
CL Item
No (2)
CL Item
Yes (3)
Item Group
Study Conclusion
C1707478 (UMLS CUI-1)
C0008972 (UMLS CUI-2)
Study completion
Item
Did the patient complete the study as planned?
boolean
C2826674 (UMLS CUI [1])
Item
If "no", mark the one most appropriate category
integer
C2348235 (UMLS CUI [1])
Specification
Code List
If "no", mark the one most appropriate category
CL Item
Adverse Event (complete Adverse Event Form) (1)
CL Item
Insufficient therapeutic effect (2)
CL Item
Deviation from Protocol (including non-compliance) (3)
CL Item
Lost to Follow-Up (4)
CL Item
Other (5)
Other diseases
Item
Please specify "Other"
text
C2359476 (UMLS CUI [1])
Withdrawal
Item
Comments on reason for withdrawal:
text
C2349954 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
Date of Withdrawal
Item
Date of Withdrawal
date
C2349954 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Time of Withdrawal
Item
Time of Withdrawal
time
C2349954 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
therapy end date
Item
Date of Final Dose:
date
C1531784 (UMLS CUI [1])
Pharmaceutical Preparations
Item
Time of Final Dose
time
C0013227 (UMLS CUI [1,1])
C1522314 (UMLS CUI [1,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial